Understanding the delayed onset of action of azathioprine in IBD: are we there yet?
Atreya
Imke
I
Institute of Molecular Medicine and I. Medical Clinic, University of Mainz, Langenbeckstrasse 1, D-55131 Mainz, Germany.
Neurath
Markus F
MF
D017209:Apoptosis; D001379:Azathioprine / Q000493:pharmacokinetics / Q000627:therapeutic use*; D015195:Drug Design; D005260:Female; D006801:Humans; D007156:Immunologic Memory; D007166:Immunosuppressive Agents / Q000493:pharmacokinetics / Q000627:therapeutic use*; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy*; D008297:Male; D013601:T-Lymphocytes / Q000276:immunology
D007166:Immunosuppressive Agents; D001379:Azathioprine